GL1X · GenesisL1 explorer

Research workbench

Xray crystal structure of lysozyme mutant L20/R63A liganded to ethylguanidinium

Analyse Xray crystal structure of lysozyme mutant L20/R63A liganded to ethylguanidinium in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2F32
Type
protein
Length
175 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysozyme
EC
3.2.1.17
UniProt
P00720
Ligands
EGD
Pockets
2 · best druggability 0.44

Structure

x-ray diffraction · 1 distinct chain · 64% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysozyme (EC 3.2.1.17)protein17564% helix, 10% strandP00720

Ligands and binding sites

  • EGD · N-ethylguanidine · ligand · chains A
  • BME · Beta-mercaptoethanol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11420.440.7620empty
2770.310.7314empty

Compared structures

  • 2F32 · Xray crystal structure of lysozyme mutant L20/R63A liganded to ethylguanidinium · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.